GW Pharmaceuticals regains exclusive commercialisation rights to Sativex® (nabiximols) in the UK from Bayer

GW Pharmaceuticals regains exclusive commercialisation rights to Sativex® (nabiximols) in the UK from Bayer

GW Pharmaceuticals plc announced that GW will regain exclusive UK commercialisation rights… Read the full article “GW Pharmaceuticals regains exclusive commercialisation rights to Sativex® (nabiximols) in the UK from Bayer” on The Daily Marijuana Observer.

Excerpt only …
READ MORE BELOW
Source : MJ OBSERVER
Link to original : GW Pharmaceuticals regains exclusive commercialisation rights to Sativex® (nabiximols) in the UK from Bayer
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.